X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-01-17 | PLRX | Coulie Bernard | Pres, CEO | S - Sale | $11.20 | -52,419 | 839,834 | -6% | -$587,150 | ||||||
2025-01-17 | PLRX | Cummings Keith Lamont | CFO | S - Sale | $11.20 | -20,148 | 262,608 | -7% | -$225,680 | ||||||
2025-01-17 | PLRX | Hull Hans | Chief Business Officer | S - Sale | $11.20 | -15,936 | 243,349 | -6% | -$178,501 | ||||||
2025-01-17 | PLRX | Lefebvre Eric | Chief Medical Officer | S - Sale | $11.20 | -18,478 | 194,574 | -9% | -$206,974 | ||||||
2025-01-17 | PLRX | Cheung Lily | Chief Human Resource Officer | S - Sale | $11.20 | -3,740 | 24,550 | -13% | -$41,892 | ||||||
| M | 2025-01-17 | PLRX | Ouimette Mike | GC, Corp. Sec'y | S - Sale | $11.11 | -23,500 | 70,544 | -25% | -$261,101 | |||||
2024-07-10 | PLRX | Lefebvre Eric | Chief Medical Officer | S - Sale | $11.56 | -12,319 | 213,052 | -5% | -$142,408 | ||||||
2024-07-10 | PLRX | Hull Hans | Chief Business Officer | S - Sale | $11.56 | -9,900 | 259,285 | -4% | -$114,444 | ||||||
2024-07-10 | PLRX | Cummings Keith Lamont | CFO | S - Sale | $11.56 | -10,911 | 282,115 | -4% | -$126,131 | ||||||
2024-07-10 | PLRX | Coulie Bernard | Pres, CEO | S - Sale | $11.56 | -38,710 | 892,253 | -4% | -$447,488 | ||||||
2024-07-10 | PLRX | Ouimette Mike | GC, Corp. Sec'y | S - Sale | $11.56 | -7,656 | 94,044 | -8% | -$88,503 | ||||||
2024-01-17 | PLRX | Cummings Keith Lamont | CFO | S - Sale | $17.23 | -9,781 | 194,605 | -5% | -$168,527 | ||||||
2024-01-17 | PLRX | Hull Hans | Chief Business Officer | S - Sale | $17.23 | -9,786 | 216,860 | -4% | -$168,613 | ||||||
2024-01-17 | PLRX | Coulie Bernard | Pres, CEO | S - Sale | $17.23 | -25,721 | 725,699 | -3% | -$443,173 | ||||||
2024-01-17 | PLRX | Lefebvre Eric | Chief Medical Officer | S - Sale | $17.23 | -10,295 | 156,920 | -6% | -$177,383 | ||||||
2024-01-17 | PLRX | Ouimette Mike | GC, Corp. Sec'y | S - Sale | $17.23 | -5,197 | 55,246 | -9% | -$89,544 | ||||||
| DM | 2023-08-03 | PLRX | Hull Hans | Chief Business Officer | S - Sale+OE | $20.01 | -34,919 | 226,646 | -13% | -$698,581 | |||||
2023-07-20 | PLRX | Ouimette Mike | GC, Corp. Sec'y | S - Sale | $17.55 | -4,755 | 60,443 | -7% | -$83,450 | ||||||
2023-07-17 | PLRX | Ouimette Mike | GC, Corp. Sec'y | S - Sale | $18.01 | -12,778 | 65,198 | -16% | -$230,120 | ||||||
2023-07-17 | PLRX | Lefebvre Eric | Chief Medical Officer | S - Sale | $18.01 | -22,321 | 167,215 | -12% | -$401,981 | ||||||
2023-07-17 | PLRX | Hull Hans | Chief Business Officer | S - Sale | $18.01 | -17,937 | 250,974 | -7% | -$323,029 | ||||||
2023-07-17 | PLRX | Cummings Keith Lamont | CFO | S - Sale | $18.01 | -19,771 | 203,999 | -9% | -$356,058 | ||||||
2023-07-17 | PLRX | Coulie Bernard | Pres, CEO | S - Sale | $18.01 | -70,150 | 751,420 | -9% | -$1,263,338 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |